Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|September 7, 2020
Druggable Targets in Endocannabinoid SignalingAnn M Gregus, Matthew W BuczynskiAlcohol (Fayetteville, N.Y.)|September 4, 2025
Alcohol use disorder-associated pain: clinical and preclinical evidenceYuyang Dong, Matthew W Buczynski, Ann M GregusNeurobiology of Pain (Cambridge, Mass.)|December 15, 2023
NAPE-PLD regulates specific baseline affective behaviors but is dispensable for inflammatory hyperalgesiaIrene Chen, Laura B Murdaugh, Cristina Miliano, et al.Pain|July 13, 2021
Sex differences in neuroimmune and glial mechanisms of painAnn M Gregus, Ian S Levine, Kelly A Eddinger, et al.Biological Psychiatry Global Open Science|September 16, 2024
The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use DisorderCristina Miliano, Luis A Natividad, Susan Quello, et al.Research Square|February 14, 2024
Effect of chronic vapor nicotine exposure on affective and cognitive behavior in male miceLaura B Murdaugh, Cristina Miliano, Irene Chen, et al.Scientific Reports|March 20, 2024
Effect of chronic vapor nicotine exposure on affective and cognitive behavior in male miceLaura B Murdaugh, Cristina Miliano, Irene Chen, et al.Journal of Neuroscience Methods|October 16, 2019
Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systemsCristina Miliano, E Reilly Scott, Laura B Murdaugh, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2012
Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptorsAnn M Gregus, Suzanne Doolen, Darren S Dumlao, et al.British Journal of Pharmacology|July 2, 2010
Quantification of brain endocannabinoid levels: methods, interpretations and pitfallsMatthew W Buczynski, Loren H ParsonsPageof 5